References
- 1. CARCILLO J.A., KELLUM J.A., Is there a role for plasmapheresis/plasma exchange therapy in septic shock, MODS, and thrombocytopenia-associated multiple organ failure? We still do not know – but perhaps we are closer, Intensive Care. Med., 2002, Oct., 28: 1373–5.
- 2. RHODES A., EVANS L.E., ALHAZZANI W., LEVY M.M., ANTONELLI M., FERRER R. et al., Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016, Intensive Care. Med., 2017, Mar., 43(3): 304–377.
- 3. HJORTH V., STENLUND G., Plasmapheresis as part of the treatment for septic shock, Scand. J. Infect. Dis., 2000, 32: 511–4.
- 4. SCHMIDT J., MANN S., MOHR V.D., LAMPERT R., FIRLA U., ZIRNGIBL H., Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis, Intensive Care. Med., 2000, 26: 532–7.
- 5. RONCO C., BRENDOLAN A., LONNEMANN G., BELLOMO R., PICCINNI P., DIGITO A., A pilot study of coupled plasma filtration with adsorption in septic shock, Crit. Care. Med., 2002, 30: 1250–1255.
- 6. BUSUND R., KOUKLINE V., UTROBIN U., NEDASHKOVSKY E., Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial, Intensive Care. Med., 2002, Oct., 28: 1434–9.
- 7. ATAMAN K., JEHMLICH M., KOCK S., NEUMANN S., LEISCHIK M., FILIPOVIC Z., HOPF H.B., Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock, Intensive Care. Med., 2002, 28: 1164–1167.
- 8. STEGMAYR B.G., BANGA R., BERGGREN L., NORDA R., RYDVALL A., VIKERFORS T., Plasma exchange as rescue therapy in multiple organ failure including acute renal failure, Crit. Care. Med., 2003, Jun., 31: 1730–6.
- 9. JOHANNES HADEM, CARSTEN HAFER, ANDREA S. SCHNEIDER, OLAF WIESNER, GERNOT BEUTEL, THOMAS FUEHNER, TOBIAS WELTE, MARIUS M. HOEPER et al., Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients, BMC Anesthesiol., 2014, 14: 24.
- 10. SCHOENBERG M.H., WEISS M., RADERMACHER P., Outcome of patients with sepsis and septic shock after ICU treatment, Langenbecks Arch. Surg., 1998, Mar., 383: 44–8.
- 11. LEVY M.M., DELLINGER R.P., TOWNSEND S.R. et al., Surviving Sepsis Campaign. The Surviving Sepsis Campaign: Results of an international guideline-based performance improvement program targeting severe sepsis, Crit. Care. Med., 2010, 38: 367–374.
- 12. LEVY M.M., RHODES A., PHILLIPS G.S. et al., Surviving Sepsis Campaign: Association between performance metrics and outcomes in a 7.5-year study, Crit. Care. Med., 2015, 43: 3–12.
- 13. LEVY M.M., PRONOVOST P.J., DELLINGER R.P. et al., Sepsis change bundles: Converting guidelines into meaningful change in behavior and clinical outcome, Crit. Care. Med., 2004, 32: S595–S597.
- 14. DAMIANI E., DONATI A., SERAFINI G. et al., Effect of performance improvement programs on compliance with sepsis bundles and mortality: A systematic review and meta-analysis of observational studies, PLoS One, 2015, 10: e0125827.
- 15. RHODES A., PHILLIPS G., BEALE R. et al., The Surviving Sepsis Campaign bundles and outcome: Results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study), Intensive Care. Med., 2015, 41: 1620–1628.
- 16. DWYER J., One Boy’s Death Moves State to Action to Prevent Others, 2012, Available at: http://www.nytimes.com/2012/12/21/nyregion/one-boys-death-moves-state-to-action-to-prevent-others.html, Accessed December 27, 2017.
- 17. SEYMOUR C.W., GESTEN F., PRESCOTT H. et al., Time to treatment and mortality during mandated emergency care for sepsis, N. Engl. J. Med., 2017, 376: 2235–2244.
- 18. LIU V.X., MOREHOUSE J.W., MARELICH G.P. et al., Multicenter implementation of a treatment bundle for patients with sepsis and intermediate lactate values, Am. J. Respir. Crit. Care. Med., 2016, 193: 1264–1270.
- 19. LEISMAN D.E., DOERFLER M.E., WARD M.F. et al., Survival benefit and cost savings from compliance with a simplified 3-hour sepsis bundle in a series of prospective, multisite, observational cohorts, Crit. Care. Med., 2017, 45: 395–406.
- 20. FERRER R., MARTIN-LOECHES I., PHILLIPS G. et al., Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: Results from a guideline-based performance improvement program, Crit. Care. Med., 2014, 42: 1749–1755.
- 21. KUMAR A., ROBERTS D., WOOD K.E. et al., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock, Crit. Care. Med., 2006, 34: 1589–1596.
- 22. KUMAR A., Systematic bias in meta-analyses of time to antimicrobial in sepsis studies, Crit. Care. Med., 2016, 44: e234–e235.
- 23. SEYMOUR C.W., LIU V.X., IWASHYNA T.J. et al., Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA, 2016, 315: 762–774.
- 24. HOEPER M.M., ABOU-REBYEH F., ATHMAN C., SCHWARZ A., Plasmapheresis in streptococcal toxic shock syndrome, Crit. Care. Med., 2001, 29: 2399.